Comparative immunogenicity of two vaccination schedules of a combined hepatitis A and B vaccine in healthy volunteers
โ Scribed by A. De Schryver; K. Verstrepen; L. Vandersmissen; N. Vandermeeren; I. Vernaillen; R. Vranckx; P. Van Damme; M. van Sprundel
- Book ID
- 108886508
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 60 KB
- Volume
- 18
- Category
- Article
- ISSN
- 1352-0504
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
A hepatitis B vaccine produced in yeast by recombinant DNA technology was evaluated using 5-micrograms and 10-micrograms doses in a randomized trial lasting 7 months in 110 male armed forces recruits aged 17-19 years. Results were compared to those of an identical trial of a plasma-derived vaccine.
We tested the safety and long-term immunogenicity of two of the early investigative lots of a recombinant-yeast-derived hepatitis B vaccine in immunocompetent adults. Three 10-micrograms doses of recombinant hepatitis B vaccine (Merck Sharp & Dohme Research Laboratories, West Point, PA) were adminis
This open, randomized study was conducted in healthy Chinese youngsters, aged between 10 and 19 years to compare the reactogenicity and immunogenicity of two vaccines: the combined vaccine against hepatitis A and B was administered in a two-dose schedule with the profile of the corresponding monoval